Literature DB >> 20359535

Cancer stem cells: back to Darwin?

Mel Greaves1.   

Abstract

Current models of cancer propagation or 'stem' cells pay scant attention to the evolutionary dynamics of cancer or to the underlying genetic, mutational drivers. Recent genetic studies on acute lymphoblastic leukaemia at the single cell level reveal a complex non-linear, branching clonal architecture-with sub-clones having distinctive genetic signatures. Most cancers appropriately interrogated are found to have intra-clonal genetic heterogeneity indicative of divergent clonal evolution. These data further suggest that clonal architecture might be driven by genetic heterogeneity of propagating or 'stem' cells. When assayed for leukaemic regeneration in NOD/SCID/gamma mice, genetically diverse 'stem' cells read-out, broadly reflecting the clonal architecture. This has suggested a 'back to Darwin' model for cancer propagation. In this, cells with self-renewal potency or 'stem-ness' provide genetically diverse units of evolutionary selection in cancer progression. The model has significant implications for targeted cancer therapy.

Entities:  

Mesh:

Year:  2010        PMID: 20359535     DOI: 10.1016/j.semcancer.2010.03.002

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  51 in total

1.  Bone marrow homing and engraftment of human hematopoietic stem and progenitor cells is mediated by a polarized membrane domain.

Authors:  Andre Larochelle; Jennifer M Gillette; Ronan Desmond; Brian Ichwan; Amy Cantilena; Alexandra Cerf; A John Barrett; Alan S Wayne; Jennifer Lippincott-Schwartz; Cynthia E Dunbar
Journal:  Blood       Date:  2012-01-06       Impact factor: 22.113

2.  CD44 is a biomarker associated with human prostate cancer radiation sensitivity.

Authors:  WeiWei Xiao; Peter H Graham; Carl A Power; Jingli Hao; John H Kearsley; Yong Li
Journal:  Clin Exp Metastasis       Date:  2011-09-28       Impact factor: 5.150

3.  Modelling acute leukemias in mice: clonal evolution and the emergence of leukemic stem cells.

Authors:  Bastien Gerby; Trang Hoang
Journal:  BMC Proc       Date:  2013-04-04

Review 4.  Heterogeneity maintenance in glioblastoma: a social network.

Authors:  Rudy Bonavia; Maria-del-Mar Inda; Webster K Cavenee; Frank B Furnari
Journal:  Cancer Res       Date:  2011-05-31       Impact factor: 12.701

5.  Regulation of stem cells-related signaling pathways in response to doxorubicin treatment in Hs578T triple-negative breast cancer cells.

Authors:  Oana Tudoran; Olga Soritau; Loredana Balacescu; Simona Visan; Otilia Barbos; Roxana Cojocneanu-Petric; Ovidiu Balacescu; Ioana Berindan-Neagoe
Journal:  Mol Cell Biochem       Date:  2015-07-18       Impact factor: 3.396

Review 6.  BRCA1--conductor of the breast stem cell orchestra: the role of BRCA1 in mammary gland development and identification of cell of origin of BRCA1 mutant breast cancer.

Authors:  Niamh E Buckley; Paul B Mullan
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

Review 7.  Evolutionary medicine: its scope, interest and potential.

Authors:  Stephen C Stearns
Journal:  Proc Biol Sci       Date:  2012-08-29       Impact factor: 5.349

Review 8.  How animal models of leukaemias have already benefited patients.

Authors:  Julien Ablain; Rihab Nasr; Jun Zhu; Ali Bazarbachi; Valérie Lallemand-Breittenbach; Hugues de Thé
Journal:  Mol Oncol       Date:  2013-02-11       Impact factor: 6.603

9.  Population genetics of cancer cell clones: possible implications of cancer stem cells.

Authors:  Christopher T Naugler
Journal:  Theor Biol Med Model       Date:  2010-11-09       Impact factor: 2.432

Review 10.  Understanding the cancer stem cell.

Authors:  S Bomken; K Fiser; O Heidenreich; J Vormoor
Journal:  Br J Cancer       Date:  2010-07-27       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.